Parkinson Disease

Featured Article
True or false: The FDA recently approved a deep brain stimulation system for Parkinson disease.
In a new study, researchers aimed to determine whether a combination of drugs used to treat benign prostatic hyperplasia was associated with a decreased risk of developing Parkinson disease.
This deep brain stimulation system—the fourth generation of the system since 2012—was approved as an adjunctive therapy for certain patients with Parkinson disease.
In a new study, researchers have found that nutritional approaches may be a key avenue in slowing the onset of Parkinson disease.
This news roundup features new findings presented at the MDS Virtual 2020 Congress, including the key role loneliness may play in Parkinson disease (PD) severity, as well as superiority data on directional vs omnidirectional deep brain stimulation in PD.
In an analysis of nearly 3000 elderly men without Parkinson disease (PD) at baseline, researchers aimed to determine whether circadian abnormalities were associated with an increased risk of PD over time.
Past research has shown an association between psychiatric symptoms and cognitive performance in patients with Parkinson disease, but how does mild cognitive impairment status affect this association? Authors of a new study sought to find answers.
In a new study, researchers used the largest aggregate of genome-wide association studies data to identify novel risk loci and gained further insight into the causes of Parkinson disease.
Authors of a new study evaluated whether 30 to 45 minutes of aerobic exercise 3 times a week for 6 months—which was gamified to promote adherence—can attenuate off-state motor symptoms in patients with Parkinson disease with mild disease severity.
There has been recent discussion about the association between the peripheral nervous system and neurodegenerative disorders. Do you think the peripheral nervous system is where PD begins?
By utilizing wearable technology, authors of a new study determined whether gait characteristics could be early diagnostic markers of prodromal Parkinson disease.